Back to top

Tale of the Tape: Archive

Zacks Equity Research

Hecla Mining (HL) is an Incredible Growth Stock: 3 Reasons Why

Hecla Mining (HL) could produce exceptional returns because of its solid growth attributes.

HLPositive Net Change

Zacks Equity Research

3 Reasons Growth Investors Will Love Kontoor (KTB)

Kontoor (KTB) is well positioned to outperform the market, as it exhibits above-average growth in financials.

KTBPositive Net Change

Zacks Equity Research

3 Reasons Why Growth Investors Shouldn't Overlook Fair Isaac (FICO)

Fair Isaac (FICO) possesses solid growth attributes, which could help it handily outperform the market.

FICONegative Net Change

Zacks Equity Research

3 Reasons Why Growth Investors Shouldn't Overlook Life Time Group Holdings (LTH)

Life Time Group Holdings (LTH) could produce exceptional returns because of its solid growth attributes.

LTHPositive Net Change

Zacks Equity Research

Here is Why Growth Investors Should Buy LeMaitre (LMAT) Now

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

LMATNegative Net Change

Zacks Equity Research

Here is Why Growth Investors Should Buy Neurocrine (NBIX) Now

Neurocrine (NBIX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

NBIXPositive Net Change

Zacks Equity Research

3 Reasons Why Growth Investors Shouldn't Overlook Orla Mining (ORLA)

Orla Mining (ORLA) is well positioned to outperform the market, as it exhibits above-average growth in financials.

ORLAPositive Net Change

Zacks Equity Research

Houlihan Lokey (HLI) is an Incredible Growth Stock: 3 Reasons Why

Houlihan Lokey (HLI) possesses solid growth attributes, which could help it handily outperform the market.

HLINegative Net Change

Zacks Equity Research

Why Green Brick Partners (GRBK) Might be Well Poised for a Surge

Green Brick Partners (GRBK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

GRBKPositive Net Change

Zacks Equity Research

Earnings Estimates Moving Higher for Isabella Bank (ISBA): Time to Buy?

Isabella Bank Corporation (ISBA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

ISBANegative Net Change

Zacks Equity Research

Can nLight (LASR) Run Higher on Rising Earnings Estimates?

nLight (LASR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

LASRPositive Net Change

Zacks Equity Research

Can On Holding (ONON) Run Higher on Rising Earnings Estimates?

On Holding (ONON) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

ONONPositive Net Change

Zacks Equity Research

Earnings Estimates Rising for CNA Financial (CNA): Will It Gain?

CNA Financial (CNA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

CNAPositive Net Change

Zacks Equity Research

Luminar Technologies (LAZR) Upgraded to Buy: What Does It Mean for the Stock?

Luminar Technologies (LAZR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

LAZRPositive Net Change

Zacks Equity Research

All You Need to Know About BigBear.ai (BBAI) Rating Upgrade to Buy

BigBear.ai (BBAI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BBAINegative Net Change

Zacks Equity Research

Applied Therapeutics (APLT) Upgraded to Buy: Here's Why

Applied Therapeutics (APLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

APLTPositive Net Change

Zacks Equity Research

Ensign Group (ENSG) is a Great Momentum Stock: Should You Buy?

Does Ensign Group (ENSG) have what it takes to be a top stock pick for momentum investors? Let's find out.

ENSGNegative Net Change

Zacks Equity Research

Barrick Mining (B) Upgraded to Buy: Here's Why

Barrick Mining (B) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BPositive Net Change

Zacks Equity Research

What Makes Hyliion (HYLN) a New Buy Stock

Hyliion (HYLN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

HYLNPositive Net Change

Zacks Equity Research

Vipshop (VIPS) Upgraded to Buy: Here's Why

Vipshop (VIPS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

VIPSPositive Net Change

Zacks Equity Research

Guess (GES) Upgraded to Buy: Here's What You Should Know

Guess (GES) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

GESPositive Net Change

Zacks Equity Research

Banco De Chile (BCH) Is Up 0.66% in One Week: What You Should Know

Does Banco De Chile (BCH) have what it takes to be a top stock pick for momentum investors? Let's find out.

BCHPositive Net Change

Zacks Equity Research

Are You Looking for a Top Momentum Pick? Why Ventas (VTR) is a Great Choice

Does Ventas (VTR) have what it takes to be a top stock pick for momentum investors? Let's find out.

VTRPositive Net Change

Zacks Equity Research

Cardinal Health (CAH) Is Up 2.00% in One Week: What You Should Know

Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

CAHNegative Net Change

Zacks Equity Research

What Makes Chime Financial, Inc. (CHYM) a New Buy Stock

Chime Financial, Inc. (CHYM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CHYMPositive Net Change